检测寡转移性乳腺癌的转移模式:18F-FDG PET/CT与常规CT成像的对比分析
该回顾性研究在慕尼黑工业大学纳入80例患者共150幅18F-FDG PET/CT图像,比较其与常规CT对寡转移性乳腺癌转移模式的判定。45.3%的病例中两种影像方法对是否存在寡转移性疾病的评估不同,仅32%病例转移模式完全一致,PET/CT在33.3%病例中检出额外转移。
要点
- 45.3%的病例中18F-FDG PET/CT与常规CT对寡转移性疾病是否存在判定不同。
- 仅32%的病例两种影像方法观察到完全一致的转移模式。
- 18F-FDG PET/CT在33.3%的病例中检出额外转移,多位于非区域淋巴结系统。
核心结论
- 18F-FDG PET/CT对乳腺癌寡转移性疾病的定义和转移模式检测有实质性影响。
- 作者强调未来试验和临床实践中需建立影像学方法的标准化定义。
研究设计与样本
- 回顾性研究,在慕尼黑工业大学纳入80例患者共150幅18F-FDG PET/CT图像,时间范围为2006年10月至2022年1月。
- 纳入标准为18F-FDG PET/CT时存在寡转移性疾病,定义为1-5个远处转移灶。
- 系统比较18F-FDG PET/CT与常规CT上的转移模式。
主要发现
- 18F-FDG PET/CT时,21.3%的患者(n=32)为首次诊断转移性疾病,40.7%(n=61)有寡转移性疾病病史,38%(n=57)有多转移性疾病病史。
- 45.3%的病例中影像方法(18F-FDG PET/CT vs. 常规CT)对是否存在寡转移性疾病的评估有影响。
- 仅32%的病例观察到完全一致的转移模式。
- 18F-FDG PET/CT在33.3%的病例中检出额外转移,多位于非区域淋巴结系统。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metastasis-directed therapy has the potential to improve progression-free and overall survival in oligometastatic disease (OMD). For breast cancer, however, randomized trials have failed so far to confirm this finding. Because the concept of metastasis-directed therapy in OMD is highly dependent on the accuracy of the imaging modality, we aimed to assess the impact of 18F-FDG PET/CT on the definition of OMD in breast cancer patients. Methods: Eighty patients with a total of 150 18F-FDG PET/CT images (between October 2006 and January 2022) were enrolled in this retrospective study at the Technical University of Munich. The inclusion criteria were OMD, defined as 1-5 distant metastases, at the time of 18F-FDG PET/CT. For the current study, we systemically compared the metastatic pattern on 18F-FDG PET/CT with conventional CT. Results: At the time of 18F-FDG PET/CT, 21.3% of patients (n = 32) had a first-time diagnosis of metastatic disease, 40.7% (n = 61) had a previous history of OMD, and 38% (n = 57) had a previous history of polymetastatic disease. In 45.3% of cases, the imaging modality (18F-FDG PET/CT vs. conventional CT) had an impact on the assessment of whether OMD was present. An identical metastatic pattern was observed in only 32% of cases.18F-FDG PET/CT detected additional metastases in 33.3% of cases, mostly in the nonregional lymph node system. Conclusion: The use of 18F-FDG PET/CT had a substantial impact on the definition of OMD and detection of metastatic pattern in breast cancer. Our results emphasize the importance of establishing a standardized definition for imaging modalities in future trials and clinical practices related to metastasis-directed therapy in breast cancer patients.
引用
- Moser R, Pfeiffer S, Cala L, et al. Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of 18F-FDG PET/CT and Conventional CT Imaging. J Nucl Med. 2024. PMID: 38637138. doi:10.2967/jnumed.123.266925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。